Your browser doesn't support javascript.
loading
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis.
Weisel, Kathleen; Berger, Scott; Thorn, Katie; Taylor, Peter C; Peterfy, Charles; Siddall, Hilary; Tompson, Debra; Wang, Susanne; Quattrocchi, Emilia; Burriss, Susan W; Walter, Jochen; Tak, Paul Peter.
Afiliação
  • Weisel K; GlaxoSmithKline, Collegeville, PA, USA.
  • Berger S; GlaxoSmithKline, Collegeville, PA, USA.
  • Thorn K; GlaxoSmithKline, Stockley Park, Uxbridge, UK.
  • Taylor PC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Peterfy C; Spire Sciences, Inc., Boca Raton, FL, USA.
  • Siddall H; GlaxoSmithKline Medicine Research Center, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK. hilary.x.siddall@gsk.com.
  • Tompson D; GlaxoSmithKline Medicine Research Center, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
  • Wang S; GlaxoSmithKline, Collegeville, PA, USA.
  • Quattrocchi E; GlaxoSmithKline, Stockley Park, Uxbridge, UK.
  • Burriss SW; GlaxoSmithKline, Collegeville, PA, USA.
  • Walter J; Rheumatologische Schwerpunktpraxis, Rendsburg, Germany.
  • Tak PP; GlaxoSmithKline Medicine Research Center, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
Arthritis Res Ther ; 23(1): 85, 2021 03 16.
Article em En | MEDLINE | ID: mdl-33726834

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxazepinas / Artrite Reumatoide / Antirreumáticos / Pesquisa Biomédica Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxazepinas / Artrite Reumatoide / Antirreumáticos / Pesquisa Biomédica Idioma: En Ano de publicação: 2021 Tipo de documento: Article